About-us technologies products Clinical-trials collaborations news careers contact-us
About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>

About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

Recent News

Paris (France),
11th-14th June, 2014

Philogen will be presenting pre-clinical and clinical data on immunocytokines Tetravil and Dekavil at the EULAR conference in Paris, 11th-14th June. Please see Press Release summarizing the interim Phase Ib trial data for Dekavil.

Upcoming Events

Zurich (Switzerland),
September 1st, 2014

Philochem is organizing the 4th International symposium on DNA-encoded chemical libraries in Zurich, 1st September.
Please download the Flyer.